Feb 13, 2023
Wall Street ends sharply higher as investors eye inflation data

(Updates following end of session with price moves) By Noel Randewich (Reuters) - Wall Street closed sharply higher on Monday as investors awaited inflation data likely to hint at the path of the Federal Reserve's future interest rate hikes, while…

Feb 13, 2023
As ChatGPT’s popularity explodes, U.S. lawmakers take an interest

By Diane Bartz WASHINGTON (Reuters) - ChatGPT, a fast-growing artificial intelligence program, has drawn praise for its ability to write answers quickly to a wide range of queries, and attracted U.S. lawmakers' attention with questions about its impact on national…

Feb 10, 2023
A boy and his boat help Chile firefighters combat blazes

By Cristobal Saavedra RIO FUTA, Chile (Reuters) - As his parents fought wildfires threatening their home in southern Chile, 13-year-old Lucas Cespedes decided to take action, ferrying firefighters across the local river in a small yellow rowing boat to help…

Feb 10, 2023
Walmart pushes back as major product suppliers ask for higher prices

By Siddharth Cavale and Jessica DiNapoli NEW YORK (Reuters) -Walmart Inc is warning major packaged goods makers that it can no longer stomach their price hikes, pitching its own private-label products to shoppers as less-expensive alternatives to suppliers' name-brand goods.…

Feb 09, 2023
Meta restores Donald Trump’s access to Facebook, Instagram

(Reuters) -Meta Platforms Inc has restored former U.S. President Donald Trump's access to Facebook and Instagram, Meta spokesperson Andy Stone confirmed on Thursday, following a two-year suspension after the deadly Capitol Hill riot on Jan. 6, 2021. Meta in January…

Feb 08, 2023
Netflix lays out plans to crack down on account sharing

(Corrects syntax in headline and paragraph 1) (Reuters) - Netflix Inc on Wednesday laid out plans to crack down on password sharing for accounts on its streaming platform, including setting up primary location and paying a couple of dollars for…

Feb 06, 2023
Drug companies face COVID cliff in 2023 as sales set to plummet

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend…